Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Recruiting · NCT06410248 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-09 | NCT06410248 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BrainUp | 1 |
| Nanopharmaceutics | 1 |
| National Cancer Institute (NCI) | 3015 |
| Northwestern University | 381 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern University | Chicago | United States | 727 |